TY - JOUR
T1 - Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease
AU - Krittanawong, Chayakrit
AU - Escobar, Johao
AU - Virk, Hafeez Ul Hassan
AU - Alam, Mahboob
AU - Virani, Salim
AU - Lavie, Carl J.
AU - Narayan, K. M.Venkat
AU - Sharma, Raman
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2024/3
Y1 - 2024/3
N2 - Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.
AB - Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.
KW - Lifestyle approach
KW - Lifestyle medicine
KW - PAD
KW - Peripheral artery disease
UR - http://www.scopus.com/inward/record.url?scp=85179497745&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2023.10.028
DO - 10.1016/j.amjmed.2023.10.028
M3 - Review article
C2 - 37980970
AN - SCOPUS:85179497745
SN - 0002-9343
VL - 137
SP - 202
EP - 209
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 3
ER -